Key mechanisms include: Appetite suppression Liraglutide acts on receptors in the brain's appetite centres, particularly the hypothalamus, reducing hunger and increasing feelings of fullness [11] [12] Delayed gastric emptying The medication slows the rate at which food leaves the stomach, prolonging satiety after meals Improved glycaemic control Liraglutide enhances insulin secretion in response to elevated blood glucose and suppresses inappropriate glucagon release Saxenda is administered as a once-daily subcutaneous injection, with doses gradually increased over five weeks from 0.6 mg to the maintenance dose of 3.0 mg daily
(Note: This is a separate booking tool linked below!) Address : 90 N
Think of it as a cellular cleanup crew
Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
BPC-157, in particular, has demonstrated protective effects against NSAID-induced gastric damage and may act on nitric oxide pathways to maintain vascular homeostasis
Thankfully, we offer Semaglutide for weight loss, which doesnt just curb cravingsit uniquely helps reduce that deeper, more dangerous belly fat, often yielding superior outcomes compared to lifestyle changes alone
